United Kingdom· GB-APID-38842911000001103
Dapsone 100mg tablets
A dapsone product containing dapsone, registered in United Kingdom by Rivopharm (UK) Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Dapsone is registered in 10 of 19 countries.
Countries holding a registration under ATC J04BA02 (dapsone), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Dapsone · ATC J04BA02
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Dapsone
- Manufacturer
- Rivopharm (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- J04BA02
- ATC class
- Dapsone
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060388650889
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for dapsone.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dapsone · interactions on record
415 records
- 7 severe
- 206 moderate
- 2 minor
- 200 info
Most severe, free to view
- SaquinavirJ05AE01severe
- CladribineL01BB04severe
- Aminolevulinic acidL01XD04severe
- CladribineL04AA40severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dapsone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDapsoneChartwell RX, LLC
- CanadaMAR-DAPSONEMARCAN PHARMACEUTICALS INC
- NetherlandsDapson Tiofarma 100 mg, tablettenTiofarma B.V.
- PolandDusalmAdamed Pharma S.A.
- NorwayDapsonScanpharm
- GermanyDapson ZentivaZentiva Pharma Gmbh
- Japanジアフェニルスルホン田辺ファーマ
- SpainSULFONA COMPRIMIDOSEsteve Pharmaceuticals S.A.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Dapson Zentiva, Dapson-Fatol
- Denmark · Dapson Scanpharm
- Malta · Dapsone Tillomed Laboratories
- Netherlands · Dapson Tiofarma
- Norway · Dapson Scanpharm
- Poland · Dusalm
- Portugal · Sulfona Zimaia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e95af762-c6bf-4ddc-879a-17efa8a27cb4 GET /v1/drugs/e95af762-c6bf-4ddc-879a-17efa8a27cb4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38842911000001103",
"desc": "Dapsone 100mg tablets (Rivopharm (UK) Ltd)",
"form": "Oral tablet",
"vpid": "41947811000001109",
"source": "dmd",
"vtm_id": "775449004",
"strength": "100 mg",
"substance": "Dapsone",
"ingredient": "Dapsone",
"supplier_code": "28601711000001107"
}See everything about dapsone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.